Discover Financial Services closed 0.96% below its 52-week high of $188.99, which the company reached on January 15th.

Cemiplimab significantly reduced the risk of recurrence or death in patients with high-risk cutaneous squamous cell carcinoma ...

Certified Financial Planner (CFP) Shashin Shah, Managing Director at SFMG Wealth Advisors, noted that his main financial ...

Discover Financial Services DFS is scheduled to release fourth-quarter 2024 results on Jan. 22, after the closing bell. The ...

Discover Financial Services (NYSE:DFS) had its price target lowered by JPMorgan Chase & Co. from $150.00 to $146.00 in a ...

( NewsNation) — A technical glitch at Capital One bank has thousands of customers reporting problems with missing direct ...